e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Mucosal immunology: what’s new in 2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Severe asthma is characterised by high levels of CRTH2 expressing cells in peripheral blood
Bart Hilvering (Utrecht, Netherlands), Bart Hilvering, Linda Stoeger, Svenja Pahlke, Luzheng Xue, Ian Pavord
Source:
International Congress 2015 – Mucosal immunology: what’s new in 2015
Session:
Mucosal immunology: what’s new in 2015
Session type:
Poster Discussion
Number:
378
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bart Hilvering (Utrecht, Netherlands), Bart Hilvering, Linda Stoeger, Svenja Pahlke, Luzheng Xue, Ian Pavord. Severe asthma is characterised by high levels of CRTH2 expressing cells in peripheral blood. Eur Respir J 2015; 46: Suppl. 59, 378
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Peripheral blood Th17 / Treg ratio increases in late asthmatic response
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic
Source: Annual Congress 2013 –Asthma
Year: 2013
Heterogeneous levels of CD86+CD209+ and CD83+CD209+ dendritic cells in patients with different severity of bronchial asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Expression of Th1, Th2 and Th17 cytokines in CD4
+
T cells in peripheral blood of asthma patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Importance of levels production of Il-4 in the pathogenesis and formation of the phenotype of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
ARRY-502, a potent, selective, oral CRTh2 antagonist reduces Th2 mediators in patients with mild to moderate Th2-driven asthma
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Association between T-regulatory cells blood content and Th2 cells activity in asthma
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Imbalance of pro-inflammatory and anti-inflammatory markers on circulating dendritic cells in COPD
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Differences in response to Der p1 and bacterial lipopolysaccharide in peripheral blood mononuclear cells from severe and non-severe asthmatics
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Bronchial thermoplasty resulted in an increase of CD4+CD25+ regulatory T cells in severe asthma patients
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Higher burden of asthma symptoms and increased blood eosinophils in ACOS
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Increased serum levels of soluble IL-18 receptor complex in allergic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Immunology indices in severe bronchial asthma with different levels of disease control in children
Source: Annual Congress 2013 –Asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept